IBDEI0I8 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8202,1,3,0)
 ;;=3^Thyroiditis,Subacute
 ;;^UTILITY(U,$J,358.3,8202,1,4,0)
 ;;=4^E06.1
 ;;^UTILITY(U,$J,358.3,8202,2)
 ;;=^119376
 ;;^UTILITY(U,$J,358.3,8203,0)
 ;;=C73.^^39^394^19
 ;;^UTILITY(U,$J,358.3,8203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8203,1,3,0)
 ;;=3^Malig Neop of Thyroid Gland
 ;;^UTILITY(U,$J,358.3,8203,1,4,0)
 ;;=4^C73.
 ;;^UTILITY(U,$J,358.3,8203,2)
 ;;=^267296
 ;;^UTILITY(U,$J,358.3,8204,0)
 ;;=E16.2^^39^394^10
 ;;^UTILITY(U,$J,358.3,8204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8204,1,3,0)
 ;;=3^Hypoglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,8204,1,4,0)
 ;;=4^E16.2
 ;;^UTILITY(U,$J,358.3,8204,2)
 ;;=^5002708
 ;;^UTILITY(U,$J,358.3,8205,0)
 ;;=E20.0^^39^394^15
 ;;^UTILITY(U,$J,358.3,8205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8205,1,3,0)
 ;;=3^Idiopathic Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,8205,1,4,0)
 ;;=4^E20.0
 ;;^UTILITY(U,$J,358.3,8205,2)
 ;;=^5002712
 ;;^UTILITY(U,$J,358.3,8206,0)
 ;;=E20.9^^39^394^11
 ;;^UTILITY(U,$J,358.3,8206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8206,1,3,0)
 ;;=3^Hypoparathyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,8206,1,4,0)
 ;;=4^E20.9
 ;;^UTILITY(U,$J,358.3,8206,2)
 ;;=^5002714
 ;;^UTILITY(U,$J,358.3,8207,0)
 ;;=E23.0^^39^394^12
 ;;^UTILITY(U,$J,358.3,8207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8207,1,3,0)
 ;;=3^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,8207,1,4,0)
 ;;=4^E23.0
 ;;^UTILITY(U,$J,358.3,8207,2)
 ;;=^60685
 ;;^UTILITY(U,$J,358.3,8208,0)
 ;;=E27.1^^39^394^34
 ;;^UTILITY(U,$J,358.3,8208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8208,1,3,0)
 ;;=3^Primary Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,8208,1,4,0)
 ;;=4^E27.1
 ;;^UTILITY(U,$J,358.3,8208,2)
 ;;=^5002740
 ;;^UTILITY(U,$J,358.3,8209,0)
 ;;=E27.2^^39^394^1
 ;;^UTILITY(U,$J,358.3,8209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8209,1,3,0)
 ;;=3^Addisonian Crisis
 ;;^UTILITY(U,$J,358.3,8209,1,4,0)
 ;;=4^E27.2
 ;;^UTILITY(U,$J,358.3,8209,2)
 ;;=^263725
 ;;^UTILITY(U,$J,358.3,8210,0)
 ;;=E27.3^^39^394^4
 ;;^UTILITY(U,$J,358.3,8210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8210,1,3,0)
 ;;=3^Drug-induced Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,8210,1,4,0)
 ;;=4^E27.3
 ;;^UTILITY(U,$J,358.3,8210,2)
 ;;=^5002741
 ;;^UTILITY(U,$J,358.3,8211,0)
 ;;=E29.1^^39^394^35
 ;;^UTILITY(U,$J,358.3,8211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8211,1,3,0)
 ;;=3^Testicular Hypofunction
 ;;^UTILITY(U,$J,358.3,8211,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,8211,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,8212,0)
 ;;=E55.9^^39^394^42
 ;;^UTILITY(U,$J,358.3,8212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8212,1,3,0)
 ;;=3^Vitamin D Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,8212,1,4,0)
 ;;=4^E55.9
 ;;^UTILITY(U,$J,358.3,8212,2)
 ;;=^5002799
 ;;^UTILITY(U,$J,358.3,8213,0)
 ;;=E66.01^^39^394^20
 ;;^UTILITY(U,$J,358.3,8213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8213,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,8213,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,8213,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,8214,0)
 ;;=E66.8^^39^394^24
 ;;^UTILITY(U,$J,358.3,8214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8214,1,3,0)
 ;;=3^Obesity NEC
 ;;^UTILITY(U,$J,358.3,8214,1,4,0)
 ;;=4^E66.8
 ;;^UTILITY(U,$J,358.3,8214,2)
 ;;=^5002831
 ;;^UTILITY(U,$J,358.3,8215,0)
 ;;=E66.9^^39^394^25
